Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report

Recombinant interferon beta ‐1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea. AbstractRecombinant interferon beta ‐1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.

Source: Clinical Case Reports - May 25, 2020 Category: General Medicine Authors: Mrinal Gupta, Paul S. Yamauchi, Martine Bagot, Jacek Szepietowski, Shibani Bhatia, Torello Lotti, Mohamad Goldust Tags: CASE REPORT Source Type: research